Canada markets closed

TFF Pharmaceuticals, Inc. (0K3.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.5950-0.0300 (-4.80%)
At close: 09:15AM CEST
Full screen
Loading interactive chart...
  • GlobeNewswire

    TFF Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results

    FORT WORTH, Texas, March 07, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today reported fourth quarter and full year 2022 financial results. “TFF Pharmaceuticals is pursuing our new product development strategy and we are focused on advancing our two lead clinical candidates, Inhale

  • GlobeNewswire

    TFF Pharmaceuticals to Participate in the 35th Annual Roth Conference

    FORT WORTH, Texas, March 06, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform, today announced that CEO Harlan Weisman, M.D. will be participating in a Fireside Chat at the 35th Annual Roth Conference being held in-person at The Ritz Carlton, Laguna Niguel in Dana Point on March 12-14, 2023. Company management

  • GlobeNewswire

    TFF Pharmaceuticals Appoints Harlan Weisman, M.D. as Permanent Chief Executive Officer

    Dr. Harlan Weisman and recently appointed Chief Medical Officer Dr. Zamaneh Mikhak to Provide an Overview of the Corporate Strategy and 2023 Objectives Conference Call and Webcast Scheduled for Thursday, February 16, 2023, 4:30 p.m. ET FORT WORTH, Texas, Feb. 08, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platfor